Research map: Dexamethasone-Free Antiemetic Prophylaxis for Children and Adolescents Receiving Highly Emetogenic Chemotherapy: A Multicenter, Phase III, Noninferiority Trial (CIVIC POD)

Back to the article

Papers in this map

  1. Applied Logistic Regression · David W. Hosmer · 2013 · 13851 citations · Cited by this paper
  2. Statistical and Methodological Considerations in the Evaluation of Ultra-Low-Dose Nivolumab · 2026 · Related
  3. Comparative analysis of two rates · Olli S. Miettinen · 1985 · 1121 citations · Cited by this paper
  4. Virtual Sustained Tobacco Treatment for Patients With Cancer: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) Within the National Cancer Institute Community Oncology Research Program · 2026 · Related
  5. Antiemetics: ASCO Guideline Update · Paul Joseph Hesketh · 2020 · 479 citations · Cited by this paper
  6. Innovate or Be Left Behind: A Path to Prospective External Control Arms for Accelerated Oncology Drug Development · 2026 · Related
  7. Systematic Review of the Toxicity of Long-Course Oral Corticosteroids in Children · Fahad Aljebab · 2017 · 174 citations · Cited by this paper
  8. AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group · 2026 · Related
  9. Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis · Steven M. Grunberg · 2006 · 156 citations · Cited by this paper
  10. Clinical and Psychological Outcomes After Monoclonal Gammopathy Screening: A Population-Based Screening Study and Subsequent Randomized Trial of Follow-Up · 2026 · Related
  11. Systematic review of the toxicity of short-course oral corticosteroids in children · Fahad Aljebab · 2016 · 141 citations · Cited by this paper
  12. Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor · 2026 · Related
  13. Guideline for the prevention of acute chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A focused update · Priya Patel · 2017 · 128 citations · Cited by this paper
  14. SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1–High, Locally Advanced, Unresectable or Metastatic Non–Small Cell Lung Cancer · 2026 · Related
  15. Development and Validation of the Pediatric Nausea Assessment Tool for Use in Children Receiving Antineoplastic Agents · L. Lee Dupuis · 2006 · 120 citations · Cited by this paper
  16. Moderate Hypofractionation for Regional Node Irradiation Is Safe and Effective · 2026 · Related
  17. Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India · Nandana Das · 2022 · 88 citations · Cited by this paper
  18. Beyond Statistical Significance: Methodological Fragility and Censoring Bias in the 5-Year Update of CheckMate 743 · 2026 · Related
  19. Classification of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline · Edric Paw Cho Sing · 2019 · 72 citations · Cited by this paper
  20. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia · M.E. Elmantaser · 2010 · 71 citations · Cited by this paper
  21. Dexamethasone exposure and memory function in adult survivors of childhood acute lymphoblastic leukemia: A report from the SJLIFE cohort · Michelle N. Edelmann · 2013 · 59 citations · Cited by this paper
  22. Prevention of acute and delayed chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline · Priya Patel · 2022 · 57 citations · Cited by this paper
  23. Intravenous fosaprepitant for the prevention of chemotherapy‐induced vomiting in children: A double‐blind, placebo‐controlled, phase III randomized trial · Venkatraman Srinivasan Radhakrishnan · 2018 · 41 citations · Cited by this paper
  24. The Safety of Olanzapine in Young Children: A Systematic Review and Meta-Analysis · Jacqueline Flank · 2014 · 34 citations · Cited by this paper
  25. Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy: Investigator-Initiated, Randomized, Open-Label Trial · Ramavath Devendra Naik · 2020 · 33 citations · Cited by this paper
  26. Interventions for the prevention of acute phase chemotherapy-induced nausea and vomiting in adult and pediatric patients: a systematic review and meta-analysis · Priya Patel · 2022 · 29 citations · Cited by this paper
  27. Olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy–induced vomiting in children: An open‐label, randomized phase 3 trial · Venkatraman Srinivasan Radhakrishnan · 2020 · 28 citations · Cited by this paper
  28. Chemotherapy-Induced Nausea and Vomiting Prophylaxis: Practice Within the Children's Oncology Group · Priya Patel · 2016 · 27 citations · Cited by this paper
  29. Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen Selection · Hoda Pourhassan · 2024 · 22 citations · Cited by this paper
  30. Treatment of breakthrough and prevention of refractory chemotherapy‐induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update · Priya Patel · 2023 · 17 citations · Cited by this paper
  31. Dexamethasone dosing for prevention of acute chemotherapy‐induced vomiting in pediatric patients: A systematic review · Priya Patel · 2020 · 15 citations · Cited by this paper
  32. Anti-Emetics in Children Receiving Chemotherapy for Solid Tumors and Leukemia: Pharmacology and Optimization of Therapy for Nausea and Vomiting · Shuvadeep Ganguly · 2024 · 11 citations · Cited by this paper
  33. Dexamethasone-sparing regimen is an effective and safe alternative in overall antiemetic protection · Yanlin Gu · 2019 · 10 citations · Cited by this paper
  34. The emerging role of olanzapine in paediatric CINV control: A review · Anabella Karla Barušić · 2022 · 8 citations · Cited by this paper
  35. Efficacy and Safety of Olanzapine for the Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Systematic Review and Meta-analysis of Randomized Controlled Trials · Jagdish Prasad Meena · 2023 · 8 citations · Cited by this paper
  36. Efficacy and Safety of Olanzapine in Children Receiving Highly Emetogenic Chemotherapy: A Randomized, Double-blind Placebo-controlled Phase 3 Trial · Abdul W. Moothedath · 2022 · 6 citations · Cited by this paper
  37. Trial Sequential Analysis and Meta-Analysis of Olanzapine in Pediatric Patients for Chemotherapy-Induced Nausea and Vomiting (CINV) · Alok D. Singh · 2024 · 5 citations · Cited by this paper
  38. Increased Risk of Skeletal Toxicity and Infection in Children 10 Years or Older Treated for Acute Lymphoblastic Leukemia (ALL) with Dexamethasone: Results from the DFCI ALL Consortium. · Lynda M. Vrooman · 2007 · 4 citations · Cited by this paper
  39. Translation and Psychometric Evaluation of the Hindi Language Version of the Pediatric Nausea Assessment Tool (PeNAT) in the Indian Population · Azgar Abdul Rasheed · 2023 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)